-
1
-
-
0033935812
-
Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: Continued risk of biochemical failure after 5 years
-
Amling CL, Blute ML, Bergstralh EJ, et al. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol. 2000;164:101-105. (Pubitemid 30434268)
-
(2000)
Journal of Urology
, vol.164
, Issue.1
, pp. 101-105
-
-
Amling, C.L.1
Blute, M.L.2
Bergstralh, E.J.3
Seay, T.M.4
Slezak, J.5
Zincke, H.6
-
2
-
-
0028266043
-
Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases
-
DOI 10.1016/0090-4295(94)90180-5
-
Partin AW, Pearson JD, Landis PK, et al. Evaluation of serum prostatespecific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology. 1994;43:649-659. (Pubitemid 24145607)
-
(1994)
Urology
, vol.43
, Issue.5
, pp. 649-659
-
-
Partin, A.W.1
Pound, C.R.2
Pearson, J.D.3
Quentin Clemens, J.4
Landis, P.K.5
Epstein, J.I.6
Ballentine Carter, H.7
Walsh, P.C.8
-
3
-
-
0030815150
-
Recurrence patterns after radical retropubic prostatectomy: Clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen
-
DOI 10.1016/S0022-5347(01)64238-1
-
Patel A, Dorey F, Franklin J, et al. Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. J Urol. 1997;158:1441-1445. (Pubitemid 27391215)
-
(1997)
Journal of Urology
, vol.158
, Issue.4
, pp. 1441-1445
-
-
Patel, A.1
Dorey, F.2
Franklin, J.3
Dekernion, J.B.4
-
4
-
-
0033526309
-
Natural history of progression after PSA elevation following radical prostatectomy
-
DOI 10.1001/jama.281.17.1591
-
Pound CR, Partin AW, Eisenberger MA, et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999;281:1591-1597. (Pubitemid 29211767)
-
(1999)
Journal of the American Medical Association
, vol.281
, Issue.17
, pp. 1591-1597
-
-
Pound, C.R.1
Partin, A.W.2
Eisenberger, M.A.3
Chan, D.W.4
Pearson, J.D.5
Walsh, P.C.6
-
5
-
-
24944504498
-
Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy
-
Patel DA, Presti JC Jr, McNeal JE, et al. Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy. J Clin Oncol. 2005;23:6157-6162.
-
(2005)
J Clin Oncol
, vol.23
, pp. 6157-6162
-
-
Patel, D.A.1
Presti Jr., J.C.2
McNeal, J.E.3
-
6
-
-
22844433445
-
Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy
-
DOI 10.1001/jama.294.4.440
-
DAmico AV, Renshaw AA, Sussman B, et al. Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA. 2005;294:440-447. (Pubitemid 41124176)
-
(2005)
Journal of the American Medical Association
, vol.294
, Issue.4
, pp. 440-447
-
-
D'Amico, A.V.1
Renshaw, A.A.2
Sussman, B.3
Chen, M.-H.4
-
7
-
-
0037374728
-
18F] fluorodeoxyglucose-positron emission tomography
-
DOI 10.1097/01.ju.0000056901.95996.43
-
Picchio M, Messa C, Landoni C, et al. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. J Urol. 2003;169: 1337-1340. (Pubitemid 36323779)
-
(2003)
Journal of Urology
, vol.169
, Issue.4
, pp. 1337-1340
-
-
Picchio, M.1
Messa, C.2
Landoni, C.3
Gianolli, L.4
Sironi, S.5
Brioschi, M.6
Matarrese, M.7
Matei, D.V.8
De Cobelli, F.9
Del Maschio, A.10
Rocco, F.11
Rigatti, P.12
Fazio, F.13
-
8
-
-
33645835922
-
Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: Meaningful at PSA < 5 ng/ml?
-
DOI 10.1007/s11307-005-0023-2
-
Heinisch M, Dirisamer A, Loidl W, et al. Positron emission tomography/ computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA <5 ng/mL? Mol Imaging Biol. 2006;8:43-48. (Pubitemid 44193401)
-
(2006)
Molecular Imaging and Biology
, vol.8
, Issue.1
, pp. 43-48
-
-
Heinisch, M.1
Dirisamer, A.2
Loidl, W.3
Stoiber, F.4
Gruy, B.5
Haim, S.6
Langsteger, W.7
-
9
-
-
36849072528
-
11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer
-
DOI 10.1007/s00259-007-0581-4
-
Krause BJ, Souvatzoglou M, Tuncel M, et al. The detection rate of [11C] choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging. 2008;35:18-23. (Pubitemid 350234152)
-
(2008)
European Journal of Nuclear Medicine and Molecular Imaging
, vol.35
, Issue.1
, pp. 18-23
-
-
Krause, B.J.1
Souvatzoglou, M.2
Tuncel, M.3
Herrmann, K.4
Buck, A.K.5
Praus, C.6
Schuster, T.7
Geinitz, H.8
Treiber, U.9
Schwaiger, M.10
-
10
-
-
47749151932
-
11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer
-
DOI 10.1111/j.1464-410X.2008.07592.x
-
Schilling D, Schlemmer HP, Wagner PH, et al. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. BJU Int. 2008;102:446-451. (Pubitemid 352032836)
-
(2008)
BJU International
, vol.102
, Issue.4
, pp. 446-451
-
-
Schilling, D.1
Schlemmer, H.P.2
Wagner, P.H.3
Bottcher, P.4
Merseburger, A.S.5
Aschoff, P.6
Bares, R.7
Pfannenberg, C.8
Ganswindt, U.9
Corvin, S.10
Stenzl, A.11
-
11
-
-
69449087191
-
Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy
-
Castellucci P, Fuccio C, Nanni C, et al. Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy. J Nucl Med. 2009;50:1394-1400.
-
(2009)
J Nucl Med
, vol.50
, pp. 1394-1400
-
-
Castellucci, P.1
Fuccio, C.2
Nanni, C.3
-
12
-
-
77749249079
-
Predictive factors of [(11)C] choline PET/CT in patients with biochemical failure after radical prostatectomy
-
Giovacchini G, Picchio M, Coradeschi E, et al. Predictive factors of [(11)C] choline PET/CT in patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging. 2010;37:301-309.
-
(2010)
Eur J Nucl Med Mol Imaging.
, vol.37
, pp. 301-309
-
-
Giovacchini, G.1
Picchio, M.2
Coradeschi, E.3
-
13
-
-
77954887685
-
PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy
-
Giovacchini G, Picchio M, Scattoni V, et al. PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging. 2010;37:1106-1116.
-
(2010)
Eur J Nucl Med Mol Imaging.
, vol.37
, pp. 1106-1116
-
-
Giovacchini, G.1
Picchio, M.2
Scattoni, V.3
-
14
-
-
77955879588
-
[(18) F]-fluorocholine positron- emission/computed tomography for lymph node staging of patients with prostate cancer: Preliminary results of a prospective study
-
Poulsen MH, Bouchelouche K, Gerke O, et al. [(18) F]-fluorocholine positron- emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study. BJU Int. 2010; 106:639-644.
-
(2010)
BJU Int.
, vol.106
, pp. 639-644
-
-
Poulsen, M.H.1
Bouchelouche, K.2
Gerke, O.3
-
15
-
-
43049153221
-
Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time
-
Arlen PM, Bianco F, Dahut WL, et al. Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time. J Urol. 2008; 179:2181-2185.
-
(2008)
J Urol
, vol.179
, pp. 2181-2185
-
-
Arlen, P.M.1
Bianco, F.2
Dahut, W.L.3
-
16
-
-
34548259960
-
Methods of calculating prostatespecific antigen velocity
-
Connolly D, Black A, Murray LJ, et al. Methods of calculating prostatespecific antigen velocity. Eur Urol. 2007;52:1044-1050.
-
(2007)
Eur Urol
, vol.52
, pp. 1044-1050
-
-
Connolly, D.1
Black, A.2
Murray, L.J.3
-
17
-
-
31544463834
-
Inadequacies of the current American Joint Committee on Cancer staging sytem for prostate cancer
-
DOI 10.1002/cncr.21605
-
Taylor SH, Merriman KW, Spiess PE, et al. Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer. Cancer. 2006;106:559-565. (Pubitemid 43157618)
-
(2006)
Cancer
, vol.106
, Issue.3
, pp. 559-565
-
-
Taylor, S.H.1
Merriman, K.W.2
Spiess, P.E.3
Pisters, L.4
-
18
-
-
3042727071
-
Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
-
DAmico AV, Chen MH, Roehl KA, et al. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med. 2004;351:125-135.
-
(2004)
N Engl J Med
, vol.351
, pp. 125-135
-
-
Damico, A.V.1
Chen, M.H.2
Roehl, K.A.3
-
19
-
-
34147137270
-
Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: A report from search
-
DOI 10.1016/j.urology.2007.01.019, PII S0090429507000209
-
King CR, Freedland SJ, Terris MK, et al. Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH. Urology. 2007;69:732-737. (Pubitemid 46574938)
-
(2007)
Urology
, vol.69
, Issue.4
, pp. 732-737
-
-
King, C.R.1
Freedland, S.J.2
Terris, M.K.3
Aronson, W.J.4
Kane, C.J.5
Amling, C.L.6
Presti Jr., J.C.7
-
20
-
-
39149120824
-
Prostate specific antigen kinetics in the management of prostate cancer
-
Sengupta S, Amling C, DAmico AV, et al. Prostate specific antigen kinetics in the management of prostate cancer. J Urol. 2008;179:821-826.
-
(2008)
J Urol
, vol.179
, pp. 821-826
-
-
Sengupta, S.1
Amling, C.2
Damico, A.V.3
-
21
-
-
0032323478
-
Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy
-
DOI 10.1016/S0022-5347(01)62545-X
-
Cher ML, Bianco FJ Jr, Lam JS, et al. Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. J Urol. 1998;160:1387-1391. (Pubitemid 29480523)
-
(1998)
Journal of Urology
, vol.160
, Issue.4
, pp. 1387-1391
-
-
Cher, M.L.1
Bianco Jr., F.J.2
Lam, J.S.3
Davis, L.P.4
Grignon, D.J.5
Sakr, W.A.6
Banerjee, M.7
Pontes, J.E.8
Wood Jr., D.P.9
-
22
-
-
0037333956
-
Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy
-
DOI 10.1016/S0090-4295(02)02411-1
-
Kane CJ, Amling CL, Johnstone PA, et al. Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. Urology. 2003;61:607-611. (Pubitemid 36294200)
-
(2003)
Urology
, vol.61
, Issue.3
, pp. 607-611
-
-
Kane, C.J.1
Amling, C.L.2
Johnstone, P.A.S.3
Pak, N.4
Lance, R.S.5
Thrasher, J.B.6
Foley, J.P.7
Riffenburgh, R.H.8
Moul, J.W.9
-
23
-
-
0028090544
-
The clinical usefulness of prostate specific antigen: Update 1994
-
Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol. 1994;152:1358-1368. (Pubitemid 24326262)
-
(1994)
Journal of Urology
, vol.152
, Issue.5
, pp. 1358-1368
-
-
Partin, A.W.1
Oesterling, J.E.2
-
24
-
-
55649123911
-
PSA doubling time versus PSA velocity to predict high-risk prostate cancer: Data from the Baltimore Longitudinal Study of Aging
-
Loeb S, Kettermann A, Ferrucci L, et al. PSA doubling time versus PSA velocity to predict high-risk prostate cancer: data from the Baltimore Longitudinal Study of Aging. Eur Urol. 2008;54:1073-1080.
-
(2008)
Eur Urol
, vol.54
, pp. 1073-1080
-
-
Loeb, S.1
Kettermann, A.2
Ferrucci, L.3
-
25
-
-
20144374797
-
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy
-
DOI 10.1200/JCO.2005.06.058
-
Dotan ZA, Bianco FJ Jr, Rabbani F, et al. Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy. J Clin Oncol. 2005;23:1962-1968. (Pubitemid 46211375)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.9
, pp. 1962-1968
-
-
Dotan, Z.A.1
Bianco Jr., F.J.2
Rabbani, F.3
Eastham, J.A.4
Fearn, P.5
Scher, H.I.6
Kelly, K.W.7
Chen, H.-N.8
Schoder, H.9
Hricak, H.10
Scardino, P.T.11
Kattan, M.W.12
-
26
-
-
0028787237
-
Prostate-specific antigen variability in men without prostate cancer: Effect of sampling interval on prostatespecific antigen velocity
-
Carter HB, Pearson JD, Waclawiw Z, et al. Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostatespecific antigen velocity. Urology. 1995;45:591-596.
-
(1995)
Urology
, vol.45
, pp. 591-596
-
-
Carter, H.B.1
Pearson, J.D.2
Waclawiw, Z.3
-
27
-
-
0026755373
-
Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease
-
Carter HB, Morrell CH, Pearson JD, et al. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. Cancer Res. 1992;52:3323-3328.
-
(1992)
Cancer Res
, vol.52
, pp. 3323-3328
-
-
Carter, H.B.1
Morrell, C.H.2
Pearson, J.D.3
-
28
-
-
22144445291
-
Longitudinal PSA changes in men with and without prostate cancer: Assessment of prostate cancer risk
-
DOI 10.1002/pros.20210
-
Berger AP, Deibl M, Steiner H, et al. Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk. Prostate. 2005;64:240-245. (Pubitemid 40980865)
-
(2005)
Prostate
, vol.64
, Issue.3
, pp. 240-245
-
-
Berger, A.P.1
Deibl, M.2
Steiner, H.3
Bektic, J.4
Pelzer, A.5
Spranger, R.6
Klocker, H.7
Bartsch, G.8
Horninger, W.9
-
29
-
-
39749180009
-
Long-term prediction of prostate cancer: Prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population
-
DOI 10.1200/JCO.2007.13.1490
-
Ulmert D, Serio AM, OBrien MF, et al. Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population. J Clin Oncol. 2008;26:835-841. (Pubitemid 351398073)
-
(2008)
Journal of Clinical Oncology
, vol.26
, Issue.6
, pp. 835-841
-
-
Ulmert, D.1
Serio, A.M.2
O'Brien, M.F.3
Becker, C.4
Eastham, J.A.5
Scardino, P.T.6
Bjork, T.7
Berglund, G.8
Vickers, A.J.9
Lilja, H.10
-
30
-
-
58549106592
-
Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer
-
Vickers AJ, Savage C, OBrien MF, et al. Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer. J Clin Oncol. 2009;27:398-403.
-
(2009)
J Clin Oncol
, vol.27
, pp. 398-403
-
-
Vickers, A.J.1
Savage, C.2
Obrien, M.F.3
|